ENFERMEDAD DE PARKINSON

BIBLIOGRAFÍA

1. Parkinson J. An essay on the Shaking Palsy: Whittingham and Rowland ed. Londres, 1817.

2.  Capildeo R. Parkinson´s disease complex restyling and overcoat, en Movement Disorders: Tremor, L.J. Findley & R. Capildeo ed. Mc Millan Press Ltd, Oxford, pp 285-94, 1984.

3. De Pedro Cuesta, J. Studies of the prevalence of paralysis agitans by tracer methodology. Acta Neurol Scan 1987 (supp. 112):35.

4. Tanner CM, Chen B, Wang WZ et al. Environmental factors and Parkinson´s disease. A case control study in China. Neurology 1989, 39: 660-664.

5. Jiménez-Jiménez FJ, Gonzalez DM, Giménez Roldan S. Exposure to well water drinking and pesticides in Parkinson´s disease. Proceedings of the Ninth International Symposium on Parkinson´s disease. 57 World Congress of Neurology. Jerusalem 1988.

6. Golbe LI, Farrel TM, Davis PH. Follow-up study of early-life protective and risk factors in Parkinson´s disease. Mov Disorders 1990, 5:66-70.

7. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Dovoisin RC. A large kindred with autosomal dominant Parkinson´s disease. Ann Neurol 1990, 27: 276-282.

8. Galvin JE, Lee  VM-Y, Trojanowski JQ. Synucleinpathies. Arch Neurol 58:186-190.

9. Shapira AHV, Holt IJ, Sweeney M, Harding AE, Jenner P, Marsden CD. Mitochondrial DNA analysis in Parkinson´s disease. Mov Disorders 1990, 5: 294-7.

10.  Obeso JA, Linazasoro G, Gorospe A, Rodriguez MC, Lera G. Complications associated with chronic levodopa therapy in Parkinson´s disease, en Olanow W y Obeso JA, Dopamine agonist in early Parkinson´s disease, Wells Medical Limited, Kent, 1997, pp 11-36.

11. Gómez-Tortosa E, Irizarry MC, Gómez-Isla T, Hyman BT. Clinical and neuropathological correlates of dementia with Lewy bodies. Ann NY Acad Sci 2000; 920: 9-15..

12. Brucke T, Djamshidian S, Bencsits G, et al.  SPECT and PET imaging dopaminergic system in Parkinson´disease. J Neurol 2000; 247 (Suppl 4): 2-7.

13.  Chase T, Oh JD. Striatal mechanisms and pathologies of parkinsonian signs and motor complications. Ann Neurol 2000; 47(suppl, 1): 122-130.

14. Lang AE. Surgery for Parkinson’s disese. A critical evaluation of the state of the art. Arch. Neurol. 2000; 57: 1118-1125.

15. Hariz MI. Complications of movement disorders surgery and how to avoid them. Prog.Neurol Surg. 2000; 15: 246-265.

16. Laitinen L, Bergenheim T, Hariz M. Leksell’s posterolateral pallidotomy in the treatment of Parkinson’s disease. J.Neurosurg.1992; 76: 53-61.

17. Lozano AM, Lang AE, Gálvez-Jiménez N y cols. Effect of GPi pallidotomy on motor function in Parkinson’s disease. Lancet 1995; 346: 1383-1387.

18. Hallett M, Litvan I. Evaluation of surgery for Parkinson’s disease. A report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 1999; 53: 1910-21.

19. Benabid AL, Koudsie A, Benazzouz A, Piallat B, Van Blerkom N, Fraix V, Pollak P. Subthalamic nucleus deep brain stimulation. Prog. Neurol Surg. 2000; 15: 196-226.

20. Gill SS, Heywood P. Subthalamic nucleus lesions. Prog. Neurol Surg. 2000; 15: 188-195.

21. McCarter RI, Walton NH, Rowan AF, Gill SS, Palomo M. Cognitive functioning after subthalamic nucleotomy for refractory Parkinson’s disease. J Neurol Neurosurg Phychiatry 2000; 69: 60-69.

22. Lindvall O, Sawle G, Widner H, et all. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson`disease. Ann Neurol. 1994; 35: 172-180.15.

23. Kordower JH, Styren S, Clarke M et all. Fetal grafting for Parkinson’disease: Expresison of inmune markers in tuw patients with funtional fetal negral implants. Cell Transplant 1997; 6: 213-219.

24. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 200, 344 :710-9.

25. Greene PE, Fahn S, Tsai WY, et all. Severe spontaneous dyskinesias: a disabling complication of embryonic dopaminergic tissue implants in a subset of transplanted patients with advanced Parkinson’disease. Mov Disord 1999; 14: 904.

– LECTURAS RECOMENDADAS

-Deuchl G, Bain P, Brin M et all. Consensus statement of the movement disorder society on tremor. Mov Disord  1998;13 (Suppl 3): 2-23.

-Jankovic J. Complications and limitations of drug therapy for Parkinson`disease. Neurology 2000; 55 (Suppl. 6): S2-S6.

-Koller W. Levodopa in the treatment of the Parkinson disease. Neurology 2000; 55 (Suppl 4): S2-S7.

- Parkinson`Disease and Movement Disorders. J Jankovic and E Tolosa, edits. Third edition. Williams and Wilkins, Baltimore, 1998.

 -Stern MB. Contemporary approaches to the pharmacotherapeutic management of Parkinson`disease: A overview. Neurology 1997; 49 (Suppl 1): S2-S9.

| Sumario |